Liraglutide prevents right ventricle hypertrophy by avoiding ACE1 & ACE2 reduction in an experimental model of idiopathic pulmonary fibrosis

Juan Fandino Gomez

doi:10.1530/endoabs.49.gp52

Liraglutide prevents right ventricle hypertrophy by avoiding ACE1 & ACE2 reduction in an experimental model of idiopathic pulmonary fibrosis

Juan Fandino Gomez

Physiology

Research output: Contribution to a Journal (Peer & Non Peer) › Article

Original language	Undefined/Unknown
Journal	Endocrine Abstracts
DOIs	https://doi.org/10.1530/endoabs.49.gp52
Publication status	Published - 3 May 2017

Access to Document

10.1530/endoabs.49.gp52

Cite this

@article{3b8869e39b23441bb71a0147226fab3f,

title = "Liraglutide prevents right ventricle hypertrophy by avoiding ACE1 \& ACE2 reduction in an experimental model of idiopathic pulmonary fibrosis",

author = "\{Fandino Gomez\}, Juan",

year = "2017",

month = may,

day = "3",

doi = "10.1530/endoabs.49.gp52",

language = "Undefined/Unknown",

journal = "Endocrine Abstracts",

issn = "1479-6848",

}

TY - JOUR

T1 - Liraglutide prevents right ventricle hypertrophy by avoiding ACE1 & ACE2 reduction in an experimental model of idiopathic pulmonary fibrosis

AU - Fandino Gomez, Juan

PY - 2017/5/3

Y1 - 2017/5/3

UR - http://dx.doi.org/10.1530/endoabs.49.gp52

U2 - 10.1530/endoabs.49.gp52

DO - 10.1530/endoabs.49.gp52

M3 - Article

SN - 1479-6848

JO - Endocrine Abstracts

JF - Endocrine Abstracts

ER -

Liraglutide prevents right ventricle hypertrophy by avoiding ACE1 & ACE2 reduction in an experimental model of idiopathic pulmonary fibrosis

Access to Document

Other files and links

Cite this